Intensity Therapeutics' Unattributed - II Round

Intensity Therapeutics raised a round of funding on June 12, 2015.

Intensity Therapeutics is a biotechnology company whose mission is to greatly extend the lives of patients with cancer. Intensity Therapeutics is pioneering a new immune-based approach to treat cancer…

Articles about Intensity Therapeutics' Unattributed - II Round: